Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Shoutai Wan and Oral Progesterone for Threatened Miscarriage
NCT02633878Phase 3Completed
- Sponsor
- Heilongjiang University of Chinese Medicine
- Start
- Oct 2017
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of Shoutai Pill and progesterone in threatened miscarriage, sponsored by Heilongjiang University of Chinese Medicine. Started Oct 2017; status: completed.
02
Drugs
Shoutai Pillprogesterone
03
Conditions
threatened miscarriage
Beyond the preview
Go deeper on NCT02633878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633878.